Anixa Biosciences is trading 7.32% up at $3.52 after closing at $3.28 on September 1, 2026, with no clear company-specific announcement, earnings release, or late-breaking filing identified to explain the after-hours move.
- The latest update announced presentations at September healthcare-investor conferences scheduled for September 9–16, which do not directly explain the September 1 movement.
- Broader markets declined, making the isolated gain difficult to attribute.